AVAILABILITY OF OPIOIDS FOR CANCER PAIN - RECENT TRENDS, ASSESSMENT OF SYSTEM BARRIERS, NEW WORLD-HEALTH-ORGANIZATION GUIDELINES, AND THE RISK OF DIVERSION

被引:45
作者
JORANSON, DE
机构
[1] Pain Research Group, University of Wisconsin Medical School, Madison, WI
[2] World Health Organization Collaborating Center for Symptom Evaluation in Cancer Care, Madison, WI
关键词
D O I
10.1016/0885-3924(93)90052-W
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:353 / 360
页数:8
相关论文
共 34 条
[11]  
Cai, Correct and adequate use of narcotics for pain relief [Monograph], International workshop on cancer pain relief and research, (1992)
[12]  
Karjadi, Strategy for cancer pain relief and palliative care in Indonesia: an approach based on the health care delivery system [Monograph], National seminar and workshop on cancer pain, (1992)
[13]  
United Nations International Narcotics Control Board, Demand for and supply of opiates for medical and scientific needs, (1989)
[14]  
Joranson, Fear of addiction is an impediment to cancer pain relief: a proposal to the World Health Organization Programme on Substance Abuse, (1992)
[15]  
World Health Organization (WHO), Guidelines for opioid availability: annex 1 to the report of the expert committee on cancer pain relief and active supportive care, (1993)
[16]  
WHO news: essential drugs for palliative care, Palliat Med, 7, pp. 3-4, (1993)
[17]  
Teoh, Vainio, The status of pethidine in the WHO model list of essential drugs, Palliative Medicine, 5, pp. 185-186, (1991)
[18]  
United Nations, National authorities empowered to issue certificates and authorizations for the import and export of narcotic drugs and psychotropic substances, (1990)
[19]  
United Nations, Single convention on narcotic drugs, (1977)
[20]  
Weissman, Haddox, Opioid pseudoaddiction: an iatrogenic syndrome, Pain, 36, pp. 363-366, (1989)